Objective Older people in care homes frequently experience polypharmacy, increasing the likelihood of medicine-related burden. Pharmacists working within multidisciplinary primary care teams are ideally placed to lead on medication reviews. A randomised controlled trial placed pharmacists, with independent prescribing rights (PIPs), into older people care homes. In the intervention service, PIPs worked with general practitioners (GPs) and care home staff for 6 months, to optimise medicine management at individual resident and care home level. PIP activity included stopping medicines that were no longer needed or where potential harms outweighed benefits. This analysis of qualitative data examines health and social care stakeholders’ percept...
Objective: To evaluate studies of pharmacist-led interventions on potentially inappropriate prescrib...
BACKGROUND: For older patients with polypharmacy, medication management is a process of careful deli...
OBJECTIVE: To estimate the effectiveness, cost effectiveness (to be reported elsewhere), and safety ...
BackgroundResidents in care homes are often very frail, have complex medicine regimens and are at hi...
The role of an innovative Pharmacist Independent Prescriber (PIP) for care homes to optimise medicat...
Older people living in care homes have high levels of morbidity and are prescribed multiple medicine...
The role of an innovative Pharmacist Independent Prescriber (PIP) for care homes to optimise medicat...
Funding information: This work was supported by the UK’s National Institute of Health Research under...
Background: Residents in care homes are often very frail, have complex medicine regimens and are at ...
Older adults are particularly susceptible to iatrogenic disease and communicable diseases, such as i...
The role of an innovative Pharmacist Independent Prescriber (PIP) for care homes to optimise medicat...
Background Residents in care homes are often very frail, have complex medicine regimens and are a...
What is known and objective: With the ageing of the population also comes increasing comorbidities a...
Older people living in care homes (also called nursing homes, residential homes, skilled‐nursing fac...
Background: Providing optimal care for older adults creates many challenges for healthcare providers...
Objective: To evaluate studies of pharmacist-led interventions on potentially inappropriate prescrib...
BACKGROUND: For older patients with polypharmacy, medication management is a process of careful deli...
OBJECTIVE: To estimate the effectiveness, cost effectiveness (to be reported elsewhere), and safety ...
BackgroundResidents in care homes are often very frail, have complex medicine regimens and are at hi...
The role of an innovative Pharmacist Independent Prescriber (PIP) for care homes to optimise medicat...
Older people living in care homes have high levels of morbidity and are prescribed multiple medicine...
The role of an innovative Pharmacist Independent Prescriber (PIP) for care homes to optimise medicat...
Funding information: This work was supported by the UK’s National Institute of Health Research under...
Background: Residents in care homes are often very frail, have complex medicine regimens and are at ...
Older adults are particularly susceptible to iatrogenic disease and communicable diseases, such as i...
The role of an innovative Pharmacist Independent Prescriber (PIP) for care homes to optimise medicat...
Background Residents in care homes are often very frail, have complex medicine regimens and are a...
What is known and objective: With the ageing of the population also comes increasing comorbidities a...
Older people living in care homes (also called nursing homes, residential homes, skilled‐nursing fac...
Background: Providing optimal care for older adults creates many challenges for healthcare providers...
Objective: To evaluate studies of pharmacist-led interventions on potentially inappropriate prescrib...
BACKGROUND: For older patients with polypharmacy, medication management is a process of careful deli...
OBJECTIVE: To estimate the effectiveness, cost effectiveness (to be reported elsewhere), and safety ...